Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
3.760
-0.180 (-4.57%)
Mar 24, 2026, 2:54 PM EDT - Market open
Quanterix Employees
Quanterix had 450 employees as of December 31, 2025. The number of employees decreased by 21 or -4.46% compared to the previous year.
Employees
450
Change (1Y)
-21
Growth (1Y)
-4.46%
Revenue / Employee
$308,660
Profits / Employee
-$238,111
Market Cap
176.49M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 450 | -21 | -4.46% |
| Dec 31, 2024 | 471 | 30 | 6.80% |
| Dec 31, 2023 | 441 | 71 | 19.19% |
| Dec 31, 2022 | 370 | -90 | -19.57% |
| Dec 31, 2021 | 460 | 146 | 46.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 753 |
| InfuSystem Holdings | 473 |
| Apyx Medical | 205 |
| Sight Sciences | 186 |
| Electromed | 180 |
| Nano-X Imaging | 165 |
| Profound Medical | 162 |
| Quantum-Si incorporated | 145 |
QTRX News
- 21 days ago - Quanterix Corporation (QTRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025 - Business Wire
- 22 days ago - Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide - Business Wire
- 26 days ago - Quanterix to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026 - Business Wire
- 7 weeks ago - Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer's Disease Detection - Business Wire
- 2 months ago - Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling - Business Wire
- 2 months ago - Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire